Naomi Ledene Sayre

Title: Naomi Ledene Sayre: Innovator in Cancer Treatment

Introduction

Naomi Ledene Sayre is a prominent inventor based in San Antonio, Texas. She has made significant contributions to the field of cancer treatment through her innovative research and patented methods. With a total of two patents, her work focuses on the treatment of metastasis and related diseases.

Latest Patents

Naomi's latest patents include groundbreaking methods for treating metastasis, particularly in inhibiting bone cancer metastasis. One of her patents describes the use of antibodies that bind to connexin 43 (Cx43) hemichannels, which can either inhibit or activate channel opening. This innovative approach provides methods for detecting or treating cancers with antibodies that activate Cx43 channel opening. Additionally, her patents outline methods for treating inflammatory diseases, such as osteoarthritis, and neurological injuries, including spinal cord injuries, using antibodies that inhibit Cx43 channel opening.

Career Highlights

Naomi Ledene Sayre is affiliated with the University of Texas System, where she continues her research and development in the field of cancer treatment. Her work has garnered attention for its potential to improve therapeutic strategies for various diseases.

Collaborations

Naomi collaborates with esteemed colleagues, including Jean X Jiang and Zhiqiang An, who contribute to her research endeavors. Their combined expertise enhances the impact of her innovative work.

Conclusion

Naomi Ledene Sayre is a trailblazer in the field of cancer treatment, with her patents paving the way for new therapeutic approaches. Her dedication to research and collaboration underscores her commitment to advancing medical science.